NCT06820242

Brief Summary

The goal of this study is to conduct a feasibility open pilot study (N=5) of HIPS with virtual exit interviews among adult patients with chronic hip joint-related pain (HRP). We will use this mixed methods information to assess the feasibility, credibility, and acceptability of the HIPS intervention and optimize the program and study methodology in preparation for a pilot feasibility randomized control trial (RCT). Deliverables: \[1\] Adapt and refine open pilot protocol, patient recruitment, provider training, and other study materials. \[2\] Assess the feasibility, acceptability, and credibility of HIPS in preparation for a future feasibility RCT.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Apr 2025Sep 2026

First Submitted

Initial submission to the registry

February 6, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 11, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

April 4, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

1.1 years

First QC Date

February 6, 2025

Last Update Submit

April 14, 2026

Conditions

Keywords

chronic hip painmind-bodymindfulness

Outcome Measures

Primary Outcomes (10)

  • Proportion of Participants Who Scored Above the Midpoint on Each Subscale of the Credibility and Expectancy Questionnaire

    Assessed using the Credibility and Expectancy Questionnaire which asks the participant to indicate how much they believe, right now, that the intervention they will receive will help manage their COP and related worry. Possible scores range from 3 to 27 for both the credibility and the expectancy subscales. Higher scores represent higher credibility and expectancy.

    Baseline (0 Weeks)

  • Proportion of Participants Who Scored Above the Midpoint on the Client Satisfaction Scale

    Measured using the Client Satisfaction Scale which assess participants' satisfaction with participation in the study. The score range is 0-12. Higher scores indicate greater satisfaction.

    Post-Test (6 Weeks)

  • Feasibility of recruitment

    The percent of eligible patients approached that agree to participate.

    Baseline (0 Weeks)

  • Rate at which program was accepted, measured by number of completed program sessions

    The proportion of participants who attend ≥4 of 6 sessions.

    Post-Test (6 Weeks)

  • Feasibility of Assessments at Baseline

    Rate of participant's completion of self-report measures, with no measures missing.

    Baseline (0 Weeks)

  • Feasibility of Assessments at Post-Test

    Rate of participant's completion of self-report measures, with no measures missing.

    Post-Test (6 Weeks)

  • Feasibility of Assessments at Follow-Up

    Rate of participant's completion of self-report measures, with no measures missing.

    Follow-Up (30 Weeks)

  • Adverse Events

    Any self-reported or observed negative events related to participation

    Collected during intervention, an average of 6 weeks

  • Therapist adherence

    Rate of interventionist's delivering the programs by following the established session topics and practices

    Collected during intervention, an average of 6 weeks

  • Proportion of participants who report symptom improvements as measured by the Global Rating of Change Scale

    The proportion of participants who report overall improvement on the Global Rating of Change Scale. This measure includes a single question asking the patient to rate their change with respect to their hip condition over the last 6 weeks. Higher scores indicate better outcomes.

    Post-Test (6 Weeks)

Secondary Outcomes (10)

  • Pain Visual Analogue Scale (Pain-VAS)

    Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  • International Hip Outcome Tool (iHOT-12)

    Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  • PROMIS Pain Interference - Short Form 6b

    Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  • Multidimensional Assessment of Interoceptive Awareness (MAIA)

    Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  • International Physical Activity Questionnaire (IPAQ)

    Baseline (0 Weeks), Post-Test (6 Weeks), Follow-Up (30 Weeks)

  • +5 more secondary outcomes

Study Arms (1)

HIPS

EXPERIMENTAL

A 6-session mind-body intervention that teaches patients with chronic hip joint-related pain (HRP) coping skills (e.g., SMART goal-setting, coping thoughts, deep breathing, and progressive muscle relaxation) and pain education.

Behavioral: HIPS

Interventions

HIPSBEHAVIORAL

HIPS is a 6-session (one 30-minute session per week) mind-body intervention delivered virtually via live video by a trained physical therapist (PT). Across these six 30-minute sessions, the HIPS intervention aims to teach relaxation and coping skills (e.g., SMART goal-setting, coping thoughts, deep breathing, and progressive muscle relaxation) and provides pain education.

HIPS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Presenting with chronic (lasting ≥3 months) hip joint-related pain (HRP)
  • Age ≥18yr
  • a. If ≥45yr, the physician will confirm no osteoarthritis via X-ray (Kellgren Lawrence \[KL\] grade 0-1)
  • Score ≥3 for current hip pain on the Pain Visual Analogue Scale (Pain VAS)
  • Exhibits poor psychosocial health by meeting ≥1 of the criteria listed below:
  • Score ≥ 20 on the Pain Catastrophizing Scale (PCS)
  • Score ≤ 40 on the Pain Self-Efficacy Questionnaire (PSEQ)
  • Score ≥ 17 on the Tampa Scale for Kinesiophobia (TSK-11)
  • Exhibits sedentariness by meeting ≥1 of the criteria listed below:
  • Physically active \< 150mins/week according to the International Physical Activity Questionnaire (IPAQ)
  • Hip pain interferes with ability to be physically active
  • Dissatisfaction with current physical activity level

You may not qualify if:

  • Previous surgery on the symptomatic (painful) hip
  • Current pain referred from the lower back

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: NIH Stage Model for Behavioral Intervention Development
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 6, 2025

First Posted

February 11, 2025

Study Start

April 4, 2025

Primary Completion

April 30, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

April 17, 2026

Record last verified: 2026-04

Locations